Key takeaways:
- Most men who stop testosterone therapy do recover sperm production. A pooled analysis of 1,549 men across 30 studies found 90 percent had sperm concentration back above 20 million per milliliter within 12 months of stopping, and essentially all had recovered by 24 months (Liu et al., Lancet, 2006).
- Age and how long a man was on testosterone both predict how fast his count returns. In one clinic series of men treated with hCG after stopping TRT, 70 percent reached a total motile sperm count above 5 million within 12 months, and older men and men who had been on testosterone longer took measurably more time (Kohn et al., Fertility and Sterility, 2017).
- Recovery is not instant even when it eventually happens in full: a 2020 study found the pituitary hormone LH normalized after about 9 months off exogenous androgens on average, while sperm output took closer to 14 months and FSH closer to 19 months (Shankara-Narayana et al., Journal of Clinical Endocrinology and Metabolism, 2020).
Our previous article covered why testosterone therapy shuts down sperm production in the first place: exogenous testosterone tells the brain to stop sending the LH and FSH signal that the testes need to keep making sperm, and in real clinic data, close to 9 out of 10 men on prescribed testosterone were found to have no measurable sperm at all while taking it. The question that naturally follows is the one this article answers: once a man stops, does fertility actually come back, how long does it take, and what determines whether he is one of the men who recovers quickly, slowly, or not fully on his own.
The short version is reassuring but not simple. Most men do recover. The process is not fast, it is not the same for everyone, and a meaningful minority need help getting there. Here is what the actual data says, not what a forum thread or a single doctor's anecdote suggests.
Does fertility actually come back after stopping TRT?
For most men, yes. The clearest evidence comes from an integrated analysis that pooled individual data from 1,549 men across 30 separate studies of testosterone based hormonal contraception, a research setting that suppresses sperm production through the same mechanism as therapeutic TRT: exogenous testosterone shutting off the brain's LH and FSH signal. Once the men in these studies stopped, the probability of sperm concentration recovering to at least 20 million per milliliter, a level consistent with fertility, was 67 percent within 6 months, 90 percent within 12 months, 96 percent within 16 months, and 100 percent within 24 months (Liu et al., Lancet, 2006). Real clinic data on men actually being treated for low testosterone tells a similar story: among men who stopped testosterone therapy with no other identified cause of azoospermia, 65 percent had measurable sperm back within 6 months (Samplaski et al., Fertility and Sterility, 2014).
So the honest headline is that recovery is the expected outcome for most men. But "most" is doing real work in that sentence, and the timeline is measured in months, not days or weeks.
Why does it take months instead of days?
Because sperm are not made on demand, they are made on a fixed biological schedule that testosterone therapy does not change. A full cycle of spermatogenesis, the process that turns an early sperm precursor cell into a mature sperm ready for ejaculation, takes approximately 72 days in a man with normal hormone signaling. That is the fastest a healthy testis could plausibly restart production from scratch, which is why any intervention aimed at sperm production, recovery included, needs to be judged over a window of at least 12 weeks, not days.
Stopping TRT does not instantly restore the signal either. The hypothalamus and pituitary gland, the two structures at the base of the brain that send LH and FSH to the testes, were suppressed for as long as a man was on testosterone, and they do not switch back on the moment the last dose clears his system. A 2020 study that followed men after they stopped using exogenous androgens found the pituitary hormone LH took an average of about 9 months to normalize, sperm output took closer to 14 months, and FSH, the hormone that supports the Sertoli cells sperm depend on for development, took closer to 19 months (Shankara-Narayana et al., Journal of Clinical Endocrinology and Metabolism, 2020). A newer 2026 community based study of 247 men, comparing current users, recent past users, and men who had never used androgens, estimated a similar picture: about 12.8 months for LH and 18.9 months for FSH to return to normal after stopping (Grant et al., Journal of Clinical Endocrinology and Metabolism, 2026). Two separate signals have to come back online, LH first and FSH more slowly behind it, and sperm counts follow both.
What are the actual odds, and what changes them?
The single best predictor identified so far is a combination of a man's age and how long he was on testosterone. In a study of 66 men who presented specifically because they were trying to conceive after stopping TRT and were treated with hCG, with or without an additional medication called a SERM, short for selective estrogen receptor modulator, a pill that also pushes the pituitary to release more LH and FSH, 46 of them, 70 percent, reached a total motile sperm count above 5 million within 12 months, a level generally considered sufficient to attempt intrauterine insemination. Both older age and a longer duration of prior testosterone use independently predicted a slower return, with age at the time of stopping mattering slightly more consistently than duration across the six and twelve month marks (Kohn et al., Fertility and Sterility, 2017). In plain terms, a 28 year old who was on TRT for a year is playing a different game than a 45 year old who was on it for eight years. Both groups can recover. The younger, shorter duration group tends to get there faster.
The other consistent finding across this research is that a man's testicular reserve before he ever started testosterone matters. Men who already had lower sperm counts, smaller testes, or elevated FSH before starting TRT, signs that the testes were already working harder than normal to keep up, tend to recover more slowly and less completely than men who started with a fully healthy baseline. This is the practical reason a baseline semen analysis and hormone panel before starting testosterone is worth having: it is the only way to know afterward whether a man was starting from full capacity or from an already compromised one, which our guide to testing before starting TRT covers in more detail.
Does anything speed up recovery, or help the men who do not recover on their own?
Yes, for men who need it. The most established option is human chorionic gonadotropin, or hCG, a hormone that acts like LH and directly restarts testosterone production inside the testes without waiting for the brain's own signal to come back first. In one clinic series of 49 men with testosterone related azoospermia or severe oligozoospermia who were treated with hCG based combination therapy, often paired with a SERM, an aromatase inhibitor (a drug that blocks testosterone from converting into estrogen), or recombinant FSH depending on the individual case, 47 of them, about 96 percent, showed a documented return or improvement in sperm production, and one additional man's partner became pregnant without a follow up semen analysis on record (Wenker et al., Journal of Sexual Medicine, 2015). Recombinant FSH is sometimes added on top of hCG in men whose count does not respond to hCG alone, since FSH supports a different set of cells, the Sertoli cells, than hCG does, but FSH by itself, without hCG, has not been shown to reliably restart spermatogenesis on its own.
There is also a more preventive option worth knowing about if a man has not started TRT yet, or is deciding what to do next: enclomiphene and similar SERMs work by blocking estrogen's feedback signal at the pituitary, which raises the body's own LH and FSH rather than replacing testosterone from outside. In a small but genuinely useful proof of concept study, men given oral enclomiphene citrate maintained or increased their own sperm counts over 6 months, while a comparison group given topical testosterone gel did not, a direct demonstration that raising testosterone through the body's own signaling pathway does not carry the same fertility cost as replacing it externally (Kaminetsky et al., Journal of Sexual Medicine, 2013). Our enclomiphene article covers how that mechanism works and who it fits for men weighing testosterone options with fertility in mind.
What we're more skeptical about
A claim we see repeated informally, including from men who should know better after their own experience, is that feeling normal again is the same thing as being fertile again. It is not. The newest research on this, a 2026 study of 247 community dwelling men, found that men who had stopped using exogenous androgens within the past year still reported meaningfully worse depression, anxiety, and sexual function scores than men who had never used them, and that how a man felt was more strongly tied to pre-existing psychiatric factors than to where his hormones actually stood biochemically (Grant et al., Journal of Clinical Endocrinology and Metabolism, 2026). In other words, feeling back to normal, or not feeling back to normal, is not a reliable signal of what LH, FSH, and sperm count are actually doing. The only way to know where fertility actually stands is to test it directly, not to guess from mood or libido.
We are also skeptical of the informal advice to just "wait it out" indefinitely without ever rechecking. The data above describes averages and probabilities, not a guarantee for any one man, and a meaningful share of men, particularly older men and men who were on testosterone longest, are still short of recovery at the 12 month mark in the studies above. Waiting without retesting means a man cannot tell the difference between "still on track, just slower than average" and "not recovering on his own and needs hCG based treatment," and those two situations call for genuinely different next steps. And as with any fertility topic, we are skeptical of supplement based shortcuts here specifically: none of the mechanisms involved, restarting a suppressed LH and FSH signal, are ones an antioxidant supplement acts on, so there is no credible reason to expect one to speed this particular kind of recovery.
How does this fit into the bigger picture?
Recovery after TRT is really a story about three connected pieces: what a man's fertility looked like before he started, what actually happens biologically once he stops, and what testing tells him along the way. A baseline semen analysis and hormone panel before starting testosterone, covered in our testing guide, is what makes it possible to know whether recovery is complete rather than guessing. Reading testosterone, LH, and FSH together as a set, rather than one number at a time, is the clearest way to track where recovery actually stands month to month; our testosterone and LH articles walk through how to interpret those results. And for men who have not started testosterone yet but are considering it while still wanting biological children, alternatives like enclomiphene, clomiphene, and hCG, covered in our enclomiphene article, are worth a real conversation with a urologist before defaulting to standard TRT.
Our take
We know that recovery after stopping testosterone therapy is the expected outcome for most men, with the strongest pooled evidence showing 90 percent of men recovering meaningful sperm concentration within a year and essentially all recovering by two years. We know that the timeline is real and not optional: spermatogenesis runs on an approximately 72 day cycle no intervention can shortcut, and the brain's own LH and FSH signal needs months, not days, to come back online after being suppressed. We also know that a smaller group of men, particularly those who were older or on testosterone longest, recover more slowly or need active treatment with hCG to get there, and that hCG based therapy has a strong track record in that group specifically.
What we do not know as precisely is how to predict, for one specific man on day one of stopping, exactly which category he will fall into, since the strongest evidence describes group averages and probabilities rather than an individual forecast. The practical answer is not to assume either outcome. It is to retest on a real schedule, at minimum a semen analysis and hormone panel a few months after stopping and again around the 12 month mark, rather than judging recovery by how a man feels, and to bring in a reproductive urologist for hCG based treatment if the numbers are not moving by then.
FAQ
How long does it take to become fertile again after stopping TRT?
For most men, sperm concentration returns to a fertile range, at least 20 million per milliliter, within 12 months of stopping, with 90 percent of men reaching that point by then and essentially all men reaching it by 24 months in the largest pooled analysis available (Liu et al., Lancet, 2006).
Does everyone recover fertility after stopping testosterone therapy?
No, not on the same timeline or to the same degree. Older age and a longer duration of prior testosterone use both predict slower recovery, and some men do not recover fully on cessation alone and need hCG based treatment to restart sperm production (Kohn et al., Fertility and Sterility, 2017).
Does hCG help sperm come back faster after TRT?
Yes, for men who need it. In one clinic series, hCG based combination therapy was associated with a documented return or improvement in sperm production in about 96 percent of men with testosterone related azoospermia or severe oligozoospermia (Wenker et al., Journal of Sexual Medicine, 2015).
If I feel back to normal, does that mean my fertility has recovered?
Not reliably. A 2026 study found that how men felt after stopping exogenous androgens was more closely tied to pre-existing psychiatric factors than to where their hormones actually stood, so feeling normal is not a substitute for a semen analysis and hormone panel (Grant et al., Journal of Clinical Endocrinology and Metabolism, 2026).
When should I see a specialist instead of just waiting to recover?
If a semen analysis and hormone panel are not showing meaningful improvement by around 6 months, and especially if there is still no measurable sperm by 12 months, it is worth seeing a reproductive urologist to discuss hCG based treatment rather than continuing to wait without a plan (Kohn et al., Fertility and Sterility, 2017; Wenker et al., Journal of Sexual Medicine, 2015).
References
- Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367(9520):1412-1420. https://pubmed.ncbi.nlm.nih.gov/16650651/
- Samplaski MK, Loai Y, Wong K, Lo KC, Grober ED, Jarvi KA. Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters. Fertility and Sterility. 2014;101(1):64-69. https://pubmed.ncbi.nlm.nih.gov/24094422/
- Kohn TP, Louis MR, Pickett SM, Lindgren MC, Kohn JR, Pastuszak AW, Lipshultz LI. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertility and Sterility. 2017;107(2):351-357. https://pubmed.ncbi.nlm.nih.gov/27855957/
- Shankara-Narayana N, Yu C, Savkovic S, et al. Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men. Journal of Clinical Endocrinology and Metabolism. 2020;105(6):1827-1839. https://pubmed.ncbi.nlm.nih.gov/32030409/
- Grant B, Kean J, de Silva NL, et al. Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study. Journal of Clinical Endocrinology and Metabolism. 2026;111(9):2649-2663. https://pmc.ncbi.nlm.nih.gov/articles/PMC13466959/
- Wenker EP, Dupree JM, Langille GM, Kovac J, Ramasamy R, Lamb D, Mills JN, Lipshultz LI. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. Journal of Sexual Medicine. 2015;12(6):1334-1337. https://doi.org/10.1111/jsm.12890
- Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. Journal of Sexual Medicine. 2013;10(6):1628-1635. https://pubmed.ncbi.nlm.nih.gov/23530575/
Want to know where your own hormones and sperm parameters actually stand while stopping or considering testosterone therapy? SwimScore Complete measures concentration, motility, morphology, DNA fragmentation, and a full hormone panel together from home, processed in the same CLIA-certified labs used by fertility clinics, so recovery can be tracked with real numbers instead of guesswork.
Fertility clinics and urology practices: if patients are stopping testosterone therapy and trying to conceive, a fast baseline and follow up panel turns "wait and see" into a monitored, evidence based plan. See how SwimScore works with clinics on our clinic page.
This article is for general education and is not medical advice. Decisions about stopping testosterone therapy, timing hCG based treatment, or pursuing further fertility care should be made with a urologist, endocrinologist, or fertility specialist who knows your full history.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
